Evidence-based clinical practice guidelines for liver cirrhosis 2015
- PMID: 27246107
- DOI: 10.1007/s00535-016-1216-y
Evidence-based clinical practice guidelines for liver cirrhosis 2015
Abstract
The Japanese Society of Gastroenterology revised the evidence-based clinical practice guidelines for liver cirrhosis in 2015. Eighty-three clinical questions were selected, and a literature search was performed for the clinical questions with use of the MEDLINE, Cochrane, and Igaku Chuo Zasshi databases for the period between 1983 and June 2012. Manual searching of the latest important literature was added until August 2015. The guidelines were developed with use of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. This digest version in English introduces selected clinical questions and statements related to the management of liver cirrhosis and its complications. Branched-chain amino acids relieve hypoalbuminemia and hepatic encephalopathy and improve quality of life. Nucleoside analogues and peginterferon plus ribavirin combination therapy improve the prognosis of patients with hepatitis B virus related liver cirrhosis and hepatitis C related compensated liver cirrhosis, respectively, although the latter therapy may be replaced by direct-acting antivirals. For liver cirrhosis caused by primary biliary cirrhosis and active autoimmune hepatitis, urosodeoxycholic acid and steroid are recommended, respectively. The most adequate modalities for the management of variceal bleeding are the endoscopic injection sclerotherapy for esophageal varices and the balloon-occluded retrograde transvenous obliteration following endoscopic obturation with cyanoacrylate for gastric varices. Beta-blockers are useful for primary prophylaxis of esophageal variceal bleeding. The V2 receptor antagonist tolvaptan is a useful add-on therapy in careful diuretic therapy for ascites. Albumin infusion is useful for the prevention of paracentesis-induced circulatory disturbance and renal failure. In addition to disaccharides, the nonabsorbable antibiotic rifaximin is useful for the management of encephalopathy. Anticoagulation therapy is proposed for patients with acute-onset or progressive portal vein thrombosis.
Keywords: Antiviral therapy; Ascites; Diagnosis; Gastroesophageal varices; Hepatic encephalopathy; Hepatorenal syndrome; Liver cirrhosis; Liver transplant; Nonviral cirrhosis; Nutritional therapy.
Similar articles
-
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.J Gastroenterol. 2021 Jul;56(7):593-619. doi: 10.1007/s00535-021-01788-x. Epub 2021 Jul 7. J Gastroenterol. 2021. PMID: 34231046 Free PMC article. Review.
-
Evidence-based clinical practice guidelines for liver cirrhosis 2020.Hepatol Res. 2021 Jul;51(7):725-749. doi: 10.1111/hepr.13678. Epub 2021 Jul 6. Hepatol Res. 2021. PMID: 34228859
-
Balloon-occluded retrograde transvenous obliteration for recurrent fundal gastric variceal bleeding in an adolescent.Pediatr Transplant. 2014 Sep;18(6):E193-6. doi: 10.1111/petr.12293. Epub 2014 Jun 12. Pediatr Transplant. 2014. PMID: 24923672
-
Complications of cirrhosis.Curr Opin Gastroenterol. 2012 May;28(3):223-9. doi: 10.1097/MOG.0b013e328351d003. Curr Opin Gastroenterol. 2012. PMID: 22343347 Review.
-
Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.Am J Gastroenterol. 1997 Jul;92(7):1081-91. Am J Gastroenterol. 1997. PMID: 9219775 Review.
Cited by
-
Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II study.Int J Surg Protoc. 2023 Dec 15;28(1):1-5. doi: 10.1097/SP9.0000000000000015. eCollection 2024 Mar. Int J Surg Protoc. 2023. PMID: 38433869 Free PMC article.
-
Prediction of Esophageal Varices in Viral Hepatitis C Cirrhosis: Performance of Combined Ultrasonography and Clinical Predictors.Int J Biomed Imaging. 2023 Sep 15;2023:7938732. doi: 10.1155/2023/7938732. eCollection 2023. Int J Biomed Imaging. 2023. PMID: 37746529 Free PMC article.
-
Large Volume Paracentesis in Patients with Liver Cirrhosis Temporarily Diminishes Blood Cell Count.Iran J Med Sci. 2023 Jul;48(4):385-392. doi: 10.30476/IJMS.2022.95859.2743. Iran J Med Sci. 2023. PMID: 37456206 Free PMC article.
-
Midodrine versus Albumin to Prevent Paracentesis Induced Circulatory Dysfunction in Acute on Chronic Liver Failure Patients in the Outpatient Clinic-a Randomized Controlled Trial.J Clin Exp Hepatol. 2023 Jul-Aug;13(4):576-585. doi: 10.1016/j.jceh.2023.01.009. Epub 2023 Jan 28. J Clin Exp Hepatol. 2023. PMID: 37440947 Free PMC article.
-
LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p.J Hepatocell Carcinoma. 2023 Jun 8;10:863-881. doi: 10.2147/JHC.S410891. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37313303 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical